Effects of single oral doses of lysine clonixinate and acetylsalicylic acid on platelet functions in man

European Journal of Clinical Pharmacology

Volumn 49, Issue 5, 1996, Pages 351-354

  Pallapies, D ^a   Muhs, A ^a   Bertram, L ^a   Rohleder, G ^b   Nagyivanyi P ^b   Peskar, B A ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Roemmers SAICF   (Argentina)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Acetylsalicylic acid; Analgesia; Lysine clonixinate; Platelet aggregation; Prostaglandin F(2 ); Thromboxane B2

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CLONIXIN LYSINE; COLLAGEN; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; THROMBOXANE B2;

ADULT; ANALGESIA; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA;

ADMINISTRATION, ORAL; ADULT; ASPIRIN; BLOOD PLATELETS; CLONIXIN; COLLAGEN; CYCLOOXYGENASE INHIBITORS; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LYSINE; MALE; PLATELET AGGREGATION; THROMBOXANE B2;

EID: 0030024008     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050030     Document Type: Article

References (13)

1. Marti ML, De los Santos AR, Di Girolamo G, Gil M, Manero EO, Fraga C (1993) Lysine clonixinate in minor dental surgery: double-blind randomized parallel study versus paracetamol. Int J Tiss Reac 15:207-213
2. Osswald M, Frerick H, Maisenbacher J, Schenk N, Grabner P (1994) Schmerzbehandlung nach Weisheitszahnextraktion. Zahnärztl Welt 103:381-384
3. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 231: 232-235
4. Insel PA (1990) Analgesic-antipyretics and antiinflammatory agents: drugs employed in the treatment of rheumatoid arthritis and gout. In: Gilman AG, Rail TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. Pergamon Press, New York, pp 638-681
5. 2 production in healthy subjects. Thromb Res 17:317-327
6. 2 production in human whole blood. Thromb Res 37: 1-8
7. Marti ML, Cayetti LM, De los Santos AR, Di Girolamo G (1986) Evaluation of lysine clonixinate in osteo-arthritis of the knee. III World Conference on Clinical Pharmacology & Therapeutics, Stockholm JuK 27 August 1: Abstract 1651
8. Peskar BA, Hertting G (1973) Release of prostaglandins from isolated cat spleen by angiotensin and vasopressin. Naunyn-Schmiedeberg's Arch Pharmacol 279:227-234
9. 2 in skin-bleeding-time blood and in clotted venous blood before and after administration of acetylsalicylic acid. Lancet I: 1075-1078
10. Rubio MC (1994) Pharmacokinetics of lysine clonixinate. 1st Int Conference on Pain, Buenos Aires: Abstract 19
11. Pedersen AK, FitzGerald GA (1984) Dose-related kinetics of aspirin. N Engl J Med 311:1206-1211
12. Pallapies D, Peskar BA, Brune K, Geisslinger G (1994) Effects on platelet functions and pharmacokinetics of azapropazone and ketorolac tromethamine aiven as single parenteral doses. Br J Clin Pharmacol 37:335-339
13. Geisslinger G, Pallapies D, Brune K, Peskar BA (1994) Pharmacokinetics and effects on platelet functions of dipyrone, azapropazone and ketorolac given as single doses. Naunyn-Schmiedeberg's Arch Pharmacol 349 [Suppl]:R135